Connection
Eric Earley to Proteasome Inhibitors
This is a "connection" page, showing publications Eric Earley has written about Proteasome Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.055 |
|
|
|
-
Randall J, Evans K, Watts B, Kosasih HJ, Smith CM, Earley EJ, Erickson SW, Jocoy EL, Bult CJ, Teicher BA, de Bock CE, Smith MA, Lock RB. In vivo activity of the second-generation proteasome inhibitor ixazomib against pediatric T-cell acute lymphoblastic leukemia xenografts. Exp Hematol. 2024 Apr; 132:104176.
Score: 0.055